Estee Lauder Companies, Inc. (The) (NYSE: EL) and DS Healthcare Group (NASDAQ:DSKX) are both consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, dividends and analyst recommendations.

Volatility & Risk

Estee Lauder Companies, Inc. (The) has a beta of 0.67, suggesting that its stock price is 33% less volatile than the S&P 500. Comparatively, DS Healthcare Group has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500.

Dividends

Estee Lauder Companies, Inc. (The) pays an annual dividend of $1.36 per share and has a dividend yield of 1.2%. DS Healthcare Group does not pay a dividend. Estee Lauder Companies, Inc. (The) pays out 40.6% of its earnings in the form of a dividend. Estee Lauder Companies, Inc. (The) has raised its dividend for 3 consecutive years.

Institutional and Insider Ownership

54.6% of Estee Lauder Companies, Inc. (The) shares are owned by institutional investors. Comparatively, 8.5% of DS Healthcare Group shares are owned by institutional investors. 17.0% of Estee Lauder Companies, Inc. (The) shares are owned by insiders. Comparatively, 19.4% of DS Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Estee Lauder Companies, Inc. (The) and DS Healthcare Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Estee Lauder Companies, Inc. (The) 10.56% 32.38% 11.90%
DS Healthcare Group -104.81% N/A -196.55%

Analyst Recommendations

This is a summary of current recommendations for Estee Lauder Companies, Inc. (The) and DS Healthcare Group, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Estee Lauder Companies, Inc. (The) 0 4 17 0 2.81
DS Healthcare Group 0 0 0 0 N/A

Estee Lauder Companies, Inc. (The) presently has a consensus price target of $111.35, indicating a potential upside of 1.02%. Given Estee Lauder Companies, Inc. (The)’s higher possible upside, research analysts plainly believe Estee Lauder Companies, Inc. (The) is more favorable than DS Healthcare Group.

Earnings & Valuation

This table compares Estee Lauder Companies, Inc. (The) and DS Healthcare Group’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Estee Lauder Companies, Inc. (The) $11.82 billion 3.43 $2.35 billion $3.35 32.90
DS Healthcare Group N/A N/A N/A ($0.77) -0.02

Estee Lauder Companies, Inc. (The) has higher revenue and earnings than DS Healthcare Group. DS Healthcare Group is trading at a lower price-to-earnings ratio than Estee Lauder Companies, Inc. (The), indicating that it is currently the more affordable of the two stocks.

Summary

Estee Lauder Companies, Inc. (The) beats DS Healthcare Group on 10 of the 13 factors compared between the two stocks.

About Estee Lauder Companies, Inc. (The)

The Estee Lauder Companies Inc. manufactures and markets skin care, makeup, fragrance and hair care products. The Company offers products, including skin care, makeup, fragrance, hair care and other. The Company operates in beauty products segment. The Company’s products are sold in over 150 countries and territories under brand names, including Estee Lauder, Aramis, Clinique, Prescriptives, Lab Series, Origins, Tommy Hilfiger, MAC, Kiton, La Mer, Bobbi Brown, Donna Karan New York, DKNY, Aveda, Jo Malone London, Bumble and bumble, Michael Kors, Darphin, Tom Ford, Smashbox, Ermenegildo Zegna, AERIN, Tory Burch, RODIN olio lusso, Le Labo, Editions de Parfums Frederic Malle, GLAMGLOW, By Kilian, BECCA and Too Faced. Its skin care products include moisturizers, serums, cleansers, toners, body care, exfoliators, acne and oil correctors, facial masks, cleansing devices and sun care products.

About DS Healthcare Group

DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. Its technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells. The Company products are primarily sold under its DS Laboratories brand. It also sells certain products under its Polaris Labs and Sigma Skin brands. It markets and sells these products through salons, spas, department stores, specialty retailers and distributors. The Company offers products under three product categories: Hair Care, Skin Care and Personal Care.

Receive News & Ratings for Estee Lauder Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Estee Lauder Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.